Home/ Stocks/ LTRN

Lantern Pharma Inc. Common Stock

LTRN XNAS

$2.49 +0.01 (+0.40%) ▲ 15-min delayed

Open

$2.54

High

$2.83

Low

$2.40

Volume

242.7K

Market Cap

$32.22M

About Lantern Pharma Inc. Common Stock

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 16 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$0	$-7,072,124	$-0.57
Q1 2026	$0	$-3,329,171	$-0.30
FY 2025	$0	$-17,119,438	$-1.57
Q3 2025	$0	$-4,177,423	$-0.39

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 11, 2026

Calendar →

TickerDaily Coverage

Why Is Lantern Pharma Inc. Common Stock (LTRN) Stock Up 57.5% Today?

Penny Stocks Marcus Rivera · Mar 31, 2026

Lantern Pharma Inc. (LTRN) stock exploded higher Tuesday, March 31, 2026, jumping 57.5% to $1.88 on...

View All Coverage →

Get LTRN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Lantern Pharma Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.